You have 9 free searches left this month | for more free features.

VOD

Showing 1 - 25 of 122

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pharmacogenetics of VOD in Children With HSCT

Completed
  • Cancer
    • Paris, France
      Robert Debre Hospital
    Apr 15, 2022

    Veno-occlusive Disease, Child Trial in Seoul (lipoprostaglandin E1)

    Active, not recruiting
    • Veno-occlusive Disease
    • Child
    • lipoprostaglandin E1
    • Seoul, Chongno-gu, Korea, Republic of
      Seoul National University Hospital
    Mar 28, 2021

    Sinusoidal Obstruction Syndrome, Veno-occlusive Disease, Bone Marrow Transplant Complications Trial in Maywood (Defibrotide)

    Recruiting
    • Sinusoidal Obstruction Syndrome
    • +2 more
    • Maywood, Illinois
      Loyola University Medical Center
    Apr 22, 2021

    VOD, Ultrasound Therapy; Complications Trial in Haifa (Liver Ultrasound)

    Not yet recruiting
    • VOD
    • Ultrasound Therapy; Complications
    • Liver Ultrasound
    • Haifa, Israek, Israel
      Rambam Medical Center
    Dec 6, 2020

    Erectile Dysfunction, Erectile Dysfunction Due to Venous Disorder Trial in Cairo (Shaeer-II, PPI)

    Not yet recruiting
    • Erectile Dysfunction
    • Erectile Dysfunction Due to Venous Disorder
    • Shaeer-II
    • PPI
    • Cairo, Egypt
      Kasr El Aini Faculty of Medicine, Cairo University
    Nov 6, 2023

    Erectile Dysfunction Trial in Cairo (Shaeer-I, PPI)

    Not yet recruiting
    • Erectile Dysfunction
    • Shaeer-I
    • PPI
    • Cairo, Egypt
      Kasr El Aini Faculty of Medicine, Cairo University
    Nov 6, 2023

    Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)

    Not yet recruiting
    • Sinusoidal Obstruction Syndrome
    • Veno-occlusive Disease
    • (no location specified)
    Aug 4, 2023

    Veno-occlusive Disease Trial in Worldwide (Defibrotide, Best Supportive Care)

    Completed
    • Veno-occlusive Disease
    • Birmingham, Alabama
    • +113 more
    Feb 4, 2022

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • Acute Lymphoblastic Leukemia
    • VEN+AZA+Modified BUCY
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Apr 10, 2023

    Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure Trial in Milano

    Completed
    • Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure
    • Defibrotide Injection
    • Milano, Lombardia, Italy
      Ospedale San Raffaele
    Jul 18, 2022

    Relapsed Acute Myeloid Leukaemia Trial (Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL))

    Not yet recruiting
    • Relapsed Acute Myeloid Leukaemia
    • Cryopreserved BE CAR33 T Cells (BE752TBTTBCAR33PBL)
    • (no location specified)
    Jul 4, 2023

    Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

    Not yet recruiting
    • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
    • Inotuzumab Ozogamicin
    • (no location specified)
    Nov 3, 2022

    Penile Helicine Circulation in Veno-occlusive Erectile

    Completed
    • Erectile Dysfunction Due to Arterial Disease
    • Ultrasound and doppler
    • Latina, Italy
    • +1 more
    Mar 25, 2022

    Hepatic Veno-Occlusive Disease, Nephroblastoma, Acute Lymphoblastic Leukemia Trial in France (Blood test for genetic analysis)

    Unknown status
    • Hepatic Veno-Occlusive Disease
    • +2 more
    • Blood test for genetic analysis
    • Amiens, France
    • +15 more
    Nov 15, 2019

    MDS, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Aachen, Düsseldorf, Jena (Venetoclax, Amsacrine,

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Aachen, NRW, Germany
    • +2 more
    Mar 29, 2023

    InO - A Retrospective Study of UK Patients With Leukaemia

    Completed
    • Precursor Cell Lymphoblastic Leukemia-Lymphoma
    • Inotuzumab Ozogamicin
    • Bristol, United Kingdom
    • +3 more
    Jan 27, 2022

    European VOD Registry

    Completed
    • Hepatic Veno-Occlusive Disease
      • Angers, France
      • +52 more
      Oct 14, 2019

      Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab

      Active, not recruiting
      • Leukemia
      • +2 more
      • inotuzumab ozogamicin-dose level 2
      • Inotuzumab ozogamicin-dose level 1
      • Los Angeles, California
      • +45 more
      Mar 9, 2022

      Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5

      Withdrawn
      • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
      • +7 more
      • Inotuzumab Ozogamicin
      • +2 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 13, 2022

      Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

      Recruiting
      • Sickle Cell Disease
      • Bone Marrow Transplant (BMT)
      • +7 more
      • Atlanta, Georgia
        Children's Healthcare of Atlanta
      Sep 13, 2022

      The Endothelial Cell Dysfunction and Outcome Project for

      Not yet recruiting
      • Hematological Neoplasm
      • Endothelial Dysfunction
      • Sublingual in vivo microscopy with the Glycocheck microscope
      • (no location specified)
      Aug 14, 2022

      Sickle Cell Disease Trial in Los Angeles, Oakland (CRISPR_SCD001)

      Not yet recruiting
      • Sickle Cell Disease
      • Los Angeles, California
      • +1 more
      Apr 25, 2022

      Tumor Tissue Samples From Young Acute Lymphoblastic Leukemia

      Completed
      • Childhood Acute Lymphoblastic Leukemia in Remission
      • Recurrent Childhood Acute Lymphoblastic Leukemia
      • Laboratory Biomarker Analysis
      • Philadelphia, Pennsylvania
        Childrens Oncology Group
      Aug 12, 2022

      Fanconi Anemia Trial in Stanford (drug, device, biological)

      Recruiting
      • Fanconi Anemia
      • Stanford, California
        Stanford University
      Feb 2, 2022